Webull Thailand Named Best Online Trading Platform for US Market Access by The Global Economics
BANGKOK, Jan. 25, 2025 /PRNewswire/ -- Webull Securities (Thailand) Company Limited ("Webull Thailand"), a subsidiary of Webull Corporation, a leading digital investment platform, has been awarded the "Best Online Trading Platform for US Market...
New NCCN Patient Resource Shares Latest Understanding of Genetic Testing to Guide Patient Decision Making
Free information from the National Comprehensive Cancer Network offers information on how and why to access genetic counseling and testing for multiple hereditary cancers PLYMOUTH MEETING, Pa., Jan. 16, 2025 /PRNewswire/ -- Today, the National...
Daon Expands Presence in Japan as part of ELEMENTS' acquisition of Polarify
ELEMENTS Inc., Japan, and Daon Inc. announce a long-term agreement to collaborate on identity assurance solutions TOKYO, Jan. 16, 2025 /PRNewswire/ -- Daon®, the Digital Identity Trust company, has announced a strategic partnership with ELEMENTS,...
Scintimun® Commercialization Partnership with Curium Pharma
MELBOURNE, Australia and LIÈGE, Belgium, Jan. 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has entered into an agreement with Curium Pharma for the transfer of marketing...
Japan's leading auto leasing player Sumitomo Mitsui Auto Service acquires stake in car-sharing platform Tribecar in a push for greener mobility
Creating a sustainable future through comprehensive mobility services like car-sharing. SINGAPORE and JAPAN, Jan. 8, 2025 /PRNewswire/ -- Sumitomo Mitsui Auto Service, Japan ("SMAS") and Tribecar, Singapore ("Tribecar") will become partners in the...
Avenzo Therapeutics and DualityBio Announce Exclusive Global License for Potential Best-In-Class EGFR/HER3 Antibody-Drug Conjugate
Avenzo to receive exclusive global license (excluding Greater China) for development, manufacturing and commercialization of potential best-in-class EGFR/HER3 antibody-drug conjugate EGFR and HER3 co-expressed across various solid tumors, including...
I-Mab Announces Portfolio Prioritization of Givastomig (CLDN18.2 x 4-1BB Bispecific Antibody) as Lead Clinical Program
Givastomig: a Claudin 18.2 ("CLDN18.2") x 4-1BB bispecific antibody, will be the lead clinical program following the Company's portfolio prioritization The Company has completed enrollment of a dose escalation study of givastomig in combination with...
Huawei and Moroccan Government Boost National Education Transformation through DigiSchool Project
AGADIR, Morocco, Dec. 30, 2024 /PRNewswire/ -- Huawei has announced the successful completion of the DigiSchool 2024 project in Morocco, highlighting its contribution to ensuring equitable access to digital technology for all students in the...
Huadong Medicine Co., Ltd. and SynerK reached a strategic cooperation to jointly develop a novel siRNA drug SNK-2726
SUZHOU, China, Dec. 30, 2024 /PRNewswire/ -- Hangzhou Sino-US Huadong Medicine Co., Ltd. (hereinafter referred to as "Huadong Medicine"), a wholly-owned subsidiary of Huadong Medicine Co., Ltd. (SZ.000963), and SynerK PharmaTech (Suzhou) Co., Ltd....
NEC Thailand Partners with Umong Municipality, Lamphun Province to Develop Digital Technology Platform for Elderly Care and Smart City Advancement
LAMPHUN, Thailand, Dec. 24, 2024 /PRNewswire/ -- NEC Corporation (Thailand) Ltd., or NEC Thailand, has signed a Memorandum of Understanding (MoU) with Umong Municipality in Lamphun Province to jointly develop a digital technology platform aimed at...